Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma

Molecular therapies, including anti-IgE, biologicals and small molecules are increasingly used for treatment of asthma. The effectiveness of these therapies may be increased with biomarkers. Aim of this study was to assess the value of measuring cumulative IgE levels specific for respiratory allerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Naumova, Veronika, Beltyukov, Evgeny, Niespodziana, Katarzyna, Errhalt, Peter, Valenta, Rudolf, Karaulov, Alexander, Kiseleva, Darina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533054/
https://www.ncbi.nlm.nih.gov/pubmed/36211434
http://dx.doi.org/10.3389/fimmu.2022.941492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533054/
https://www.ncbi.nlm.nih.gov/pubmed/36211434
http://dx.doi.org/10.3389/fimmu.2022.941492

Ejemplares similares